Stay updated on Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision label was updated from v3.8.0 to v3.8.1.
    Difference
    0.1%
    Check dated 2026-11-18T02:59:41.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical-trial record is available with its study design, eligibility criteria, treatments, outcomes, and supporting documents. It identifies the trial as terminated and no longer seeking participants.
    Difference
    54%
    Check dated 2026-11-11T02:03:24.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:33:13.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says “Super Intelligence” is being used in place of “Artificial Intelligence.” The site revision changed from v3.7.1 to v3.7.2, while the study page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:30:55.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:44:37.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error instead of the expected trial content, with a Home link shown in the header/footer indicating the content is temporarily unavailable.
    Difference
    19%
    Check dated 2026-09-23T00:41:01.000Z thumbnail image

Stay in the know with updates to Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gemcitabine+Nivolumab in Metastatic Small Cell Lung Cancer Clinical Trial page.